References
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
- GoldstrawPCrowleyJChanskyKThe IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumoursJ Thorac Oncol20072870671417762336
- National Comprehensive Cancer NetworkNon-small cell lung cancer (version 3.2017)2016 Available from: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdfAccessed June 8, 2017
- GinsbergRJRubinsteinLVRandomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancerAnn Thorac Surg19956036156237677489
- MoyerVAScreening for lung cancer: U.S. Preventive Services Task Force recommendation statementAnn Intern Med2014160533033824378917
- LandreneauRJSugarbakerDJMackMJWedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancerJ Thorac Cardiovasc Surg199711346917009104978
- KhullarOVLiuYGillespieTSurvival after sublobar resection versus lobectomy for clinical stage IA lung cancerJ Thorac Oncol201510111625163326352534
- CaoCChandrakumarDGuptaSYanTDTianDHCould less be more? A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selectionLung Cancer201589212113226033208
- OkadaMNishioWSakamotoTEffect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resectionJ Thorac Cardiovasc Surg20051291879315632829
- BaoFYePYangYSegmentectomy or lobectomy for early stage lung cancer: a meta-analysisEur J Cardiothorac Surg20144611724321996
- MeryCMPappasANBuenoRSimilar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the Surveillance, Epidemiology, and End Results databaseChest2005128123724516002941
- RaziSSJohnMMSainathanSStavropoulosCSublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysisJ Surg Res2016200268368926490227
- El-SherifAFernandoHCSantosRMargin and local recurrence after sublobar resection of non-small cell lung cancerAnn Surg Oncol20071482400240517505859
- LiuSWangRZhangYPrecise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinomaJ Clin Oncol201634430731326598742
- KodamaKHigashiyamaMYokouchiHPrognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanningLung Cancer2001331172511429192
- ShimadaYYoshidaJHishidaTNishimuraMIshiiGNagaiKPredictive factors of pathologically proven noninvasive tumor characteristics in T1aN0M0 peripheral non-small cell lung cancerChest201214141003100921852293
- SuzukiKKoikeTAsakawaTA prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)J Thorac Oncol20116475175621325976
- TravisWDBrambillaENoguchiMInternational Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinomaJ Thorac Oncol20116224428521252716
- TakahashiMShigematsuYOhtaMTokumasuHMatsukuraTHiraiTTumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parametersJ Thorac Cardiovasc Surg20141471545924131786
- YehYCNitadoriJKadotaKUsing frozen section to identify histologic patterns in stage I lung adenocarcinoma ≤3 cm: accuracy and interobserver agreementHistopathology201566792293824889415
- WaltsAEMarchevskyAMRoot cause analysis of problems in the frozen section diagnosis of in situ, minimally invasive, and invasive adenocarcinoma of the lungArch Pathol Lab Med2012136121515152123194044
- CaoCManganasCAngSCYanTDA meta-analysis of unmatched and matched patients comparing video-assisted thoracoscopic lobectomy and conventional open lobectomyAnn Cardiothorac Surg201211162323977459
- BoffaDJKosinskiASPaulSMitchellJDOnaitisMLymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resectionsAnn Thorac Surg201294234735322742843
- LichtPBJørgensenODLadegaardLJakobsenEA national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancerAnn Thorac Surg201396394395023684159
- BerryMFD’AmicoTAOnaitisMWKelseyCRThoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacyAnn Thorac Surg201498119720224820392
- BlasbergJDSederCWLeversonGShanYMaloneyJDMackeRAVideo-assisted thoracoscopic lobectomy for lung cancer: current practice patterns and predictors of adoptionAnn Thorac Surg201610261854186227592603
- LiuQWangHZhouDDengXMinJDaiJComparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for stage I nonsmall cell lung cancer: a meta-analysisJ Cancer Res Ther201612292693127461676
- VannucciFGonzalez-RivasDIs VATS lobectomy standard of care for operable non-small cell lung cancer?Lung Cancer201610011411927597290
- BaoFZhangCYangYHeZWangLHuJComparison of robotic and video-assisted thoracic surgery for lung cancer: a propensity-matched analysisJ Thorac Dis2016871798180327499971
- NojiriTInoueMYamamotoKB-type natriuretic peptide as a predictor of postoperative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancerAnn Thorac Surg20119231051105521871299
- CaginiLAndolfiMLeliCB-type natriuretic peptide following thoracic surgery: a predictor of postoperative cardiopulmonary complicationsEur J Cardiothorac Surg2014465e74e8025305285
- MaYFanMDaiLThe expression of TTF-1 and napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatmentTumor Biol2015361080858092
- PircherAFieglMUntergasserGFavorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)Lung Cancer201381225225823664449
- MatikasASyrigosKNAgelakiSCirculating biomarkers in non-small-cell lung cancer: current status and future challengesClin Lung Cancer201617650751627373516
- ShangYZangALiJMicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung canerBiomed Pharmacother2016831175118127551765
- SuKZhangTWangYHaoGDiagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancerWorld J Surg Oncol201614122427733164
- IzarBSequistLLeeMThe impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancersAnn Thorac Surg201396396296823932319
- VelchetiVSchalperKACarvajalDEProgrammed death ligand-1 expression in non-small cell lung cancerLab Invest201494110711610.1038/labinvest.2013.13024217091
- TsaoMSLe TeuffGShepherdFAPD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancerAnn Oncol201728488288928137741
- WenSZhouWLiCKi-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studiesBMC Cancer20151552026174366
- LiuYWangXWangTMacrophage inhibitory cytokine-1 (MIC-1) as a biomarker for diagnosis and prognosis of stage I-II non-small cell lung cancerZhongguo Fei Ai Za Zhi2016194207215 Chinese27118648
- SpaksASvirinaDSpakaICXC chemokine ligand 4 (CXCL4) is predictor of tumour angiogenic activity and prognostic biomarker in non-small cell lung cancer (NSCLC) patients undergoing surgical treatmentBiomarkers201621547447827098116
- SunJCheSLPiaoJJXuMChenLYLinZHMortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancerTumor Biol201739319
- BerezowskaSGalvánJALangerRGlycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancerVirchows Arch2017470332333028062918
- UsóMJantus-LewintreEBremnesRMAnalysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markersOncotarget2016733528495286127463005
- Alliance for Clinical Trials in OncologyComparison of different types of surgery in treating patients with stage IA non-small cell lung cancer Available from: https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/view?cdrid=555324. NLM identifier: NCT00499330Accessed February 7, 2017
- NakamuraKSajiHNakajimaRA phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)Jpn J Clin Oncol201040327127419933688